After three decades of scientific development, clinical trial setbacks, and renewed optimism cycles that have characterized the history of gene therapy, the field has entered what many observers believe is its definitive era of clinical validation and commercial success, with an unprecedented wave of regulatory approvals, transformative patient outcomes, and massive investment creating the...